digiMedical Solutions, Inc.(TM) Focuses on New Sales Channels With Launch of digiRX Digital Prescription Web Portal

COLLEYVILLE, TX, Apr 29 (MARKET WIRE) --
digiMedical Solutions, Inc.(TM) (PINKSHEETS: DGMS) today launched a
website that will be the focal point of the services offered by
digiMedical's product digiRX(TM). The new website can be reviewed at
www.digirx.com.

digiRX(TM) is an acute care digital medical software system that provides
services to physicians, patients and pharmacies. The digiRX(TM) software
addresses the movement of prescriptions from the physician's office to the
pharmacy, with a focus on controlling the movement of Schedule II drugs,
such as OxiContin. digiRX(TM) is a thin-client system thus allowing
updates to be instantaneous to the end users. "Thin-client" means that
users only need an Internet browser to access the product. digiRX(TM) has
ancillary services providing detailed history to nurses, physicians and
pharmacists and the means to transmit prescriptions securely to any
pharmacy.

To learn more about digiRX(TM) or any of the Company's digital medical
software products, please contact the company at sales@digimedical.com or
(817) 503-8880 x 111. To be added to digiMedical's corporate e-mail list
to receive company updates, please send an e-mail to ir@digimedical.com.

About digiMedical Solutions, Inc.(TM) (www.digiMedical.com)

digiMedical Solutions, Inc.(TM) is a pharmacy and medical technology
company focused on developing next generation, digital medical technology
with an emphasis on digital prescriptions (d-Prescriptions) that closely
align the doctor, pharmacist and patient. The company's planned growth
will come from three channels: direct marketing of the company's wireless
based d-prescription technology to physicians, direct marketing of the
company's digital call center services for refills and reauthorization
and partnering with independent pharmacy chains to focus sales with the
technology suite.

Forward-Looking Statement

Statements included in this press release which are not historical in
nature, are intended to be, and are hereby identified as "Forward-Looking
Statements" for purposes of safe harbor provided by Section 21E of the
Securities Exchange Act of 1934, as amended. Forward-Looking Statements
may be identified by words including "anticipate," "await," "envision,"
"foresee," "aim at," "believe," "intends," "estimates" including without
limitation, those relating to the company's future business prospects, are
subject to certain risks and uncertainties that could cause actual results
to differ materially from those indicated in the Forward-Looking
Statements. Readers are directed to the company's filings with the U.S.
Securities and Exchange Commission.

Contact:
digiMedical Solutions, Inc.
Investor Relations
214-722-3029
ir@digimedical.com
www.digimedical.com

Copyright 2009, Market Wire, All rights reserved.

-0-